Search

Search Constraints

You searched for: Author/Creator Samuelsson, Jan

Search Results

1. A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia. (11th June 2013)

2. Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow‐up. (28th January 2020)

3. Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group. (1st January 2019)

6. Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry. (22nd February 2020)

7. Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms. Issue 10 (October 2013)

9. Survival and risk of vascular complications in myelofibrosis—A population‐based study from the Swedish MPN group. (24th June 2022)

10. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. (December 2017)